UK biotech KaNDy Therapeutics is heading to phase 3 with its non-hormonal menopause drug, after a mid-stage trial showed it reduced hot flashes as well as improved quality of life, setting up a ...
Preclinical studies mentioned above suggest that nicotine might have either a neuroprotective or a symptomatic effect in PD. In the following secttion, we will show that the nicotinic receptors ...